 | Genital HSV infections can be treated with Acyclovir / Aciclovir, antibiotics valAcyclovir / Aciclovir, or Famciclovir ( Famvir ). For children less than 12 years of age, oral Acyclovir / Aciclovir is administered at a dosage of 20 mg/kg every antibiotics eight hours. Treatment consists of intravenous (IV) administration of Acyclovir / Aciclovir. Episodic treatment of recurrent episodes is usually not necessary in childhood. Herpes simplex Virus in Children.herpes simplex virus tetracycline acne (HSV) infections are ubiquitous. Famciclovir ( Famvir ) is administered at 125 mg three times daily. Neonatal herpes simplex virus infections take one of three forms--disease localized to skin, eye, or mouth (SEM), encephalitis, or multiorgan disseminated disease.
Physician judgment is required for the management of recurrent herpes labialis, erythema multiforme, and herpes gladitorum. Children are infected with HSV resulting in totally asymptomatic acquisition to life-threatening disease. Two drops are applied to the infected eye five contemporaneity daily until resolved. Therapy of HSV diseases valtrex of children can be considered according to severity and time of acquisition. ValAcyclovir / Aciclovir is administered at 500 mg twice daily. Herpes amoxicillin simplex keratoconjunctivitis is treated with topical triflurothymidine. No controlled studies have been performed in children, although experience with Acyclovir / Aciclovir, valAcyclovir / Aciclovir, and Famciclovir ( Famvir ) have resulted in their use.. Some physicians administer oral Acyclovir / Aciclovir at the doses noted above in order to prevent frequent recurrences.
For ambulatory patients, therapy is tailored according to age. Although no controlled studies have been performed with valAcyclovir / Aciclovir or Famciclovir ( Famvir ), the pharmacokinetics of these medications would suggest superiority over Acyclovir / Aciclovir. Supportive care for patients with life-threatening disease is an integral component of patient management. Mucocutaneous HSV infections in the immunocompromised host can be treated with either intravenous Acyclovir / Aciclovir or one of the orally bioavailable antiviral therapies. For hospitalized patients, therapy consists of IV Acyclovir / Aciclovir at 5 mg/kg every 8 hours for 7 to 14 days. For postpubertal children, dosage should mirror that of adults. Dosage recommendations have not been established for young hearth.
Recurrences are managed in a similar manner. Importantly, all data on the use of these compounds for these conditions have been generated in adults.
| Location: | Madrid, Spain |
| Last access: | Tuesday, 14 April 2009, 01:32 AM (473 days 18 hours) |
|
